FDA IDE Clinical Trials: Accelerating FirstinHuman Studies

FDA IDE clinical trials allow Medtech innovators to test medical devices in humans before pivotal studies and regulatory approval. Early-stage trials often face funding gaps and long timelines, known as the Medtech “valley of death.” bioaccess® helps companies overcome these barriers by enabling first-in-human studies in Latin America, where faster approvals and efficient recruitment support rapid evidence generation. This approach helps sponsors de-risk development, validate device performance, and move confidently toward FDA IDE submissions and larger clinical trials.